Access cutting-edge resistant hypertension treatment through this clinical trial at a research site in Beverly Hills. Study-provided care at no cost to qualified participants.
Access resistant hypertension specialists in Beverly Hills at no cost
This study follows strict safety protocols and ethical guidelines
All study-related resistant hypertension treatment provided free
This is a Phase 2 dose-titration study designed to evaluate the safety and efficacy of MANP subcutaneous injection compared to placebo in reducing baseline daytime systolic blood pressure (SBP), derived from 24-hour ambulatory blood pressure monitoring (ABPM), in subjects with hypertension who are taking 3 or more antihypertensive medications with different mechanisms of action.
Sponsor: E-Star BioTech, LLC
Check if you qualify for this resistant hypertension clinical trial in Beverly Hills, CA
If you're searching for resistant hypertension treatment options in Beverly Hills, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Beverly Hills research site is actively enrolling participants for this clinical trial. You'll receive care from experienced resistant hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.